OncBioMune Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- OncBioMune Pharmaceuticals's estimated annual revenue is currently $1.4M per year.
- OncBioMune Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- OncBioMune Pharmaceuticals has 9 Employees.
- OncBioMune Pharmaceuticals grew their employee count by 0% last year.
OncBioMune Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|
OncBioMune Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5M | 32 | 19% | N/A | N/A |
#2 | $1.6M | 10 | 11% | N/A | N/A |
#3 | $96.1M | 620 | 10% | N/A | N/A |
#4 | $7.8M | 50 | -24% | N/A | N/A |
#5 | $3.1M | 20 | 25% | N/A | N/A |
#6 | $4M | 26 | 44% | N/A | N/A |
#7 | $2M | 13 | -19% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 67% | N/A | N/A |
#10 | $3.4M | 22 | -44% | $17.5M | N/A |
What Is OncBioMune Pharmaceuticals?
OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary Vaccine Technology that is designed to stimulate the immune system to attack its own cancer while not hurting the patient. Our lead product, ProscaVax(r) is scheduled to commence a Phase 2 clinical study in early 2016. OncBioMune also has a portfolio of targeted therapies, some of which are biosimilars to blockbuster drugs. OncBioMune is headquartered in Baton Rouge, LA.
keywords:N/A
N/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Baton Rouge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.7M | 9 | N/A | N/A |
#2 | $0.7M | 9 | -10% | N/A |
#3 | $0.9M | 9 | -18% | N/A |
#4 | $0.7M | 9 | 29% | N/A |
#5 | $0.7M | 9 | 0% | N/A |